Introducing Fe3O4@ SiO2@ KCC-1@ MPTMS@ CuII catalytic applications for the green one-pot syntheses of 2-aryl (or heteroaryl)-2, 3-dihydroquinazolin-4 (1H) …

MH Galehban, B Zeynizadeh, H Mousavi - Journal of Molecular Structure, 2023 - Elsevier
In this study, the new catalytic applications of the dendritic Fe 3 O 4@ SiO 2@ KCC-1@
MPTMS@ Cu II mesoporous nanocomposite have been introduced for the green one-pot …

[HTML][HTML] Systemic treatment for advanced pancreatic cancer

W Leowattana, P Leowattana… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Pancreatic cancer is a deadly disease with an extremely poor 5-year survival rate due to
treatment resistance and late-stage detection. Despite numerous years of research and …

The progress of small-molecules and degraders against BCR-ABL for the treatment of CML

Y Pan, S Zeng, R Hao, M Liang, Z Shen… - European Journal of …, 2022 - Elsevier
Chronic myeloid leukemia (CML) is a malignant disease of the hematopoietic system with
crucial pathogenic protein named BCR-ABL, which endangers the life of patients severely …

Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors

AK El-Damasy, JE Park, HJ Kim, J Lee, EK Bang… - Pharmaceuticals, 2023 - mdpi.com
Monoamine oxidase-B (MAO-B), acetylcholinesterase (AChE), and butyrylcholinesterase
(BChE) have been considered target enzymes of depression and neurodegenerative …

Approved small-molecule ATP-competitive kinases drugs containing indole/azaindole/oxindole scaffolds: R&D and binding patterns profiling

H Zhang, F He, G Gao, S Lu, Q Wei, H Hu, Z Wu… - Molecules, 2023 - mdpi.com
Kinases are among the most important families of biomolecules and play an essential role in
the regulation of cell proliferation, apoptosis, metabolism, and other critical physiological …

Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation

MM Alanazi, AS Alanazi - Molecules, 2023 - mdpi.com
Cancer is a multifactorial disorder with extremely complex genetics and progression. The
major challenge in cancer therapy is the development of cancer resistance and relapse …

Overcoming paradoxical kinase priming by a novel MNK1 inhibitor

E Bou-Petit, S Hümmer, H Alarcon… - Journal of Medicinal …, 2022 - ACS Publications
Targeting the kinases MNK1 and MNK2 has emerged as a valuable strategy in oncology.
However, most of the advanced inhibitors are acting in an adenosine triphosphate (ATP) …

Molecular dissection of Janus kinases as drug targets for inflammatory diseases

S Kwon - Frontiers in immunology, 2022 - frontiersin.org
The Janus kinase (JAK) family enzymes are non-receptor tyrosine kinases that
phosphorylate cytokine receptors and signal transducer and activator of transcription (STAT) …

[HTML][HTML] In vitro biotransformation (ivBT): definitions, opportunities, and challenges

YHP Zhang, Z Zhu, C You, L Zhang… - Synthetic Biology and …, 2023 - sciepublish.com
Great needs always motivate the birth and development of new disciplines and tools. Here
we propose in vitro BioTransformation (ivBT) as a new biomanufacturing platform, between …

An integrative epigenome-based strategy for unbiased functional profiling of clinical kinase inhibitors

F Gualdrini, S Rizzieri, S Polletti, F Pileri… - Molecular Systems …, 2024 - embopress.org
More than 500 kinases are implicated in the control of most cellular process in mammals,
and deregulation of their activity is linked to cancer and inflammatory disorders. 80 clinical …